loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 21052 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 MERCK (2)

filter

01 SUSPENSION;ORAL (2)

filter

01 DISCN (2)

filter

01 VIOXX (2)

filter

01 No (2)

URL Supplier Web Content
SUSPENSION; ORAL
12.5MG/5ML
1999-05-20
21052
VIOXX
DISCN
No
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SUSPENSION; ORAL
25MG/5ML
1999-05-20
21052
VIOXX
DISCN
No
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 21052

Looking for FDA Orange Book APPLICATION 21052 2

19

Merck & Co, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ROFECOXIB, with a corresponding application number 21052.

Regulatory Information DISCN

With a dosage strength 12.5MG/5ML

Dosage Form Route SUSPENSION; ORAL

Reference Listed Drug No

Approved since 1999-05-20

18

Merck & Co, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ROFECOXIB, with a corresponding application number 21052.

Regulatory Information DISCN

With a dosage strength 25MG/5ML

Dosage Form Route SUSPENSION; ORAL

Reference Listed Drug No

Approved since 1999-05-20

Post Enquiry
POST ENQUIRY